Envestnet Asset Management
BIVV

Envestnet Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Envestnet Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7,700
Closed -$415K – 3039
2017
Q4 		$415K Buy
7,700
+395
+5% +$21.6K ﹤0.01% 1567
2017
Q3 		$413K Buy
7,305
+141
+2% +$8.26K ﹤0.01% 1556
2017
Q2 		$425K Sell
7,164
-813
-10% -$46.3K ﹤0.01% 1567
2017
Q1 		$428K Buy
+7,977
New +$393K ﹤0.01% 1606

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Envestnet Asset Management's BIVV Position: Q1 2018 in Review

Envestnet Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 7,700 shares — an estimated $415K sold.

Envestnet Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $428K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Envestnet Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Envestnet Asset Management sold 7,700 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $415K.
  • Envestnet Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Envestnet Asset Management's Bioverativ Inc. Common Stock position peaked at $428K in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Envestnet Asset Management's 13F filing for Q1 2018, filed 9 May 2018.